No full-text available
To read the full-text of this research,
you can request a copy directly from the authors.
Insomnia Disease Treatment in Acupuncture - A Case Study in Bangladesh
Abstract
As of its popularity in eastern medicine, acupuncture treatment may help insomniacs get a good night's rest. Insomnia seems to be on the rise in the contemporary world, negatively impacting not just people's capacity to function but also their quality of life. Even if pharmaceutical therapy is beneficial, it often comes with serious side effects. The practice of acupuncture to treat insomnia has a long history in China and has recently gained widespread acceptance in the West. Numerous studies have demonstrated therapeutic uses of acupuncture for the treatment of insomnia, with many also discussing the possible processes behind the therapy. An attempt at a comprehensive overview of the relevant research will be made in this section. This research was an observational study conducted in Dhaka at Suo-Xi Hospital, Shann Tower, Chamelibag, Shantinagar Dhaka, Bangladesh. A 28-year-old man presented to the clinic complaining of sleeplessness dating back three years. We used a combination of Chinese medicine and acupuncture on the patient's scalp to help them sleep better. Excellent outcomes were found in the study's subsequent follow-up. After 12 days of acupuncture, the sleeplessness that had plagued the patient for three years began to subside. Treatment with acupuncture has been shown to aid in the functional recovery of insomnia sufferers.
ResearchGate has not been able to resolve any citations for this publication.
To determine patients' experience of outcomes after acupuncture treatment.
A patient questionnaire followed by semistructured interviews.
Acupuncture practices in York, England.
Questionnaires were distributed by 4 acupuncturists to all 132 of their patients over a 2-week period, 72 (55%) of whom responded. Of these, 11 patients were interviewed.
Patients received normal care from their acupuncturists, all of whom were members of the British Acupuncture Council.
Patients reported on physical symptoms, emotional/mental symptoms, lifestyle changes, major life changes and inner life changes affecting outlook and attitudes to health. Patients also reported on the extent they attributed change to acupuncture and what they valued about attending for treatment.
Primary reasons for attending were categorized by patients as physical symptoms (90%), mental and emotional problems (9%) and general health and well-being (1%). For physical symptoms, 75% of patients reported definite change; for emotional and mental symptoms, 67%; lifestyle changes, 40%, major life changes, 27%; and for inner life changes, 54%. Over time, many of the patients (42%) changed their primary reason for attending from their initial physical concerns, half of whom describing their new focus as related to general health and well-being. Some emotional changes were experienced by 83% of patients, irrespective of the initial reason for attending. For all these changes, 58% of patients reported that they "substantially" attributed the changes to acupuncture, and 25% "totally". The interviews provided additional data on the depth of the changes particularly for the longer term patients and on what they valued about treatment.
Treatment with acupuncture results in a broad range of outcomes from physical and emotional change through to wider benefits involving the patients' lifestyle, outlook, and attitude toward their health. Existing outcome measures are not adequate to assess these wider benefits. The results suggest that patients experienced holistic benefits from acupuncture, an outcome that could be described as holism-in-action.
Problems of sleep initiation and maintenance occur in 15% to 25% of children and adolescents. Studies of the benefits of melatonin for sleep disorders have been published for healthy populations, for children and adolescents with attention-deficit hyperactivity disorder, for children and youth with autism, and for several other special populations. These studies demonstrate benefit with minimal side effects. However, all studies have involved small numbers of subjects and address only short-term use of melatonin. There are no good data concerning the safety and efficacy of long-term melatonin use. Further studies are needed to confirm the usefulness and safety of melatonin for sleep disorders in children and adolescents.
To profile the daytime impact of the proposed DSM-5 insomnia disorder diagnosis, with and without mental health, physical health, or other sleep disorder comorbidities; to better understand how specific daytime symptom patterns are associated with nighttime sleep in insomnia; and to compare childhood-onset and adulthood-onset insomnia disorder with respect to daytime dysfunction.
Data were derived from the Great British Sleep Survey (GBSS), an open-access online population survey completed by adults who had a valid postcode and were residents of the United Kingdom. The primary variables of interest were the 6 areas that, according to the proposed DSM-5 criteria, may be impacted in the daytime by insomnia disorder: energy, concentration, relationships, ability to stay awake, mood, and ability to get through work. These variables were compared for those with versus those without insomnia disorder and across 5 insomnia subtypes (difficulty initiating sleep, difficulty maintaining sleep, early morning awakening, a combination of these 3 core symptoms, or nonrestorative sleep). Clinically comorbid insomnia presentations (insomnia disorder with poor mental health/poor physical health/additional sleep disorder symptoms) and insomnia disorder of childhood versus adult onset were also evaluated.
A total of 11,129 participants (72% female; mean age = 39 years) completed the GBSS between March 2010 and April 2011, of whom 5,083 screened as having possible insomnia disorder. Compared with those who did not have insomnia disorder, those with insomnia disorder reported greater impairment in all areas of daytime functioning (Cohen d range, 0.68-1.30). The greatest effects reflected negative impact on energy and mood. Participants with a combination of insomnia symptoms tended to be the most impaired (Cohen d range, 0.10-0.23), whereas no consistent differences emerged between the other 4 subtypes. Finally, individuals who had both insomnia disorder and poor mental health were consistently the most impaired comorbid group (Cohen d range, 0.15-0.65), and childhood-onset insomnia disorder had greater daytime impact than adult-onset insomnia disorder (P < .05 for energy; P < .01 for mood, concentration, and getting through work).
The severity of daytime impact of DSM-5 insomnia disorder varies by insomnia type. This finding has implications for the evaluation and management of insomnia in clinical practice.
Existing research indicates sleep problems to be prevalent in youth with internalizing disorders. However, childhood sleep problems are common in the general population and few data are available examining unique relationships between sleep, specific types of anxiety and depressive symptoms among non-clinical samples of children and adolescents.
The presence of sleep problems was examined among a community sample of children and adolescents (N=175) in association with anxiety and depressive symptoms, age, and gender. Based on emerging findings from the adult literature we also examined associations between cognitive biases and sleep problems.
Overall findings revealed significant associations between sleep problems and both anxiety and depressive symptoms, though results varied by age. Depressive symptoms showed a greater association with sleep problems among adolescents, while anxiety symptoms were generally associated with sleep problems in all youth. Cognitive factors (cognitive errors and control beliefs) linked with anxiety and depression also were associated with sleep problems among adolescents, though these correlations were no longer significant after controlling for internalizing symptoms.
Results are discussed in terms of their implications for research and treatment of sleep and internalizing disorders in youth.
NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults. NIH Consensus and State-of-the-Science Statements
NIH, (2005). NIH state-of-the-science conference
statement on manifestations and management of
chronic insomnia in adults. NIH Consensus and
State-of-the-Science Statements, 22(2), 1-30.
Benzo-diazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition
- T C Jacob
- G Michels
- L Silayeva
- J Haydon
- F Succol
- S J Moss
Jacob, T. C., Michels, G., Silayeva, L., Haydon, J.,
Succol, F., & Moss, S. J. (2012). Benzo-diazepine
treatment induces subtype-specific changes in
GABA(A) receptor trafficking and decreases
synaptic inhibition. Proceedings of the National
Academy of Sciences of the United States of
America, 109(45), 18595-18600.